← Evidence map

ReviewAntibiotics (Basel, Switzerland)2022

Resistance to Ceftazidime/Avibactam, Meropenem/Vaborbactam and Imipenem/Relebactam in Gram-Negative MDR Bacilli: Molecular Mechanisms and Susceptibility Testing.

Paolo Gaibani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

80 papers cite itlatest 60 shown

2022
…
2023
2024
2025
2026
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 35625273